Oppenheimer Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Oppenheimer Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,473	Closed	-$368K	–	1170
2024 Q2	$368K	Buy	4,473 +27	+0.6%	+$2.22K	﹤0.01%	932
2024 Q1	$388K	Sell	4,446 -109	-2%	-$9.52K	0.01%	899
2023 Q4	$439K	Sell	4,555 -319	-7%	-$30.8K	0.01%	894
2023 Q3	$431K	Buy	4,874 +1,535	+46%	+$136K	0.01%	885
2023 Q2	$289K	Sell	3,339 -280	-8%	-$24.3K	﹤0.01%	978
2023 Q1	$352K	Sell	3,619 -2,395	-40%	-$233K	0.01%	930
2022 Q4	$622K	Sell	6,014 -33	-0.5%	-$3.42K	0.01%	790
2022 Q3	$513K	Buy	6,047 +1,873	+45%	+$159K	0.01%	827
2022 Q2	$346K	Sell	4,174 -145	-3%	-$12K	0.01%	947
2022 Q1	$333K	Sell	4,319 -7,053	-62%	-$544K	﹤0.01%	1007
2021 Q4	$1.01M	Buy	11,372 +129	+1%	+$11.4K	0.01%	774
2021 Q3	$869K	Sell	11,243 -6,087	-35%	-$470K	0.01%	788
2021 Q2	$1.45M	Buy	17,330 +595	+4%	+$49.6K	0.02%	637
2021 Q1	$1.26M	Sell	16,735 -10,574	-39%	-$798K	0.02%	652
2020 Q4	$2.4M	Buy	27,309 +1,365	+5%	+$120K	0.04%	426
2020 Q3	$1.97M	Buy	25,944 +1,453	+6%	+$111K	0.04%	430
2020 Q2	$3.02M	Buy	24,491 +909	+4%	+$112K	0.06%	322
2020 Q1	$1.99M	Buy	23,582 +3,868	+20%	+$327K	0.05%	351
2019 Q4	$1.67M	Sell	19,714 -1,173	-6%	-$99.1K	0.04%	471
2019 Q3	$1.41M	Buy	20,887 +1,850	+10%	+$125K	0.03%	506
2019 Q2	$1.63M	Sell	19,037 -109	-0.6%	-$9.33K	0.04%	461
2019 Q1	$1.7M	Sell	19,146 -11,171	-37%	-$992K	0.04%	448
2018 Q4	$2.58M	Buy	30,317 +1	+0%	+$85	0.06%	318
2018 Q3	$2.94M	Buy	30,316 +703	+2%	+$68.1K	0.07%	321
2018 Q2	$2.79M	Buy	29,613 +3,747	+14%	+$353K	0.07%	324
2018 Q1	$2.1M	Buy	25,866 +948	+4%	+$76.8K	0.05%	370
2017 Q4	$2.32M	Hold	24,918	–	–	0.06%	329
2017 Q3	$2.32M	Buy	24,918 +75	+0.3%	+$6.98K	0.06%	331
2017 Q2	$2.26M	Buy	24,843 +1,122	+5%	+$102K	0.06%	330
2017 Q1	$2.08M	Buy	+23,721	New	+$2.08M	0.06%	343